{
  "cik": 1709941,
  "cik_padded": "0001709941",
  "entityName": "BioAge Labs, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-120873",
      "filed": "2026-03-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 719000.0,
        "cash": 188888000.0,
        "eps_diluted": -2.24,
        "free_cash_flow": -82346000.0,
        "net_income": -80605000.0,
        "operating_cash_flow": -81627000.0,
        "operating_income": -92780000.0,
        "revenue": 8995000.0,
        "stockholders_equity": 272051000.0,
        "total_assets": 294889000.0,
        "total_liabilities": 22838000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08394749513877912,
        "roa_avg2y": -0.24682946397539207,
        "roa_period_end": -0.27334013815367814,
        "roe_avg2y": -0.27086014604034425,
        "roe_period_end": -0.29628635807256726
      }
    },
    {
      "accn": "0001193125-26-120873",
      "filed": "2026-03-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 366000.0,
        "cash": 354349000.0,
        "eps_diluted": -6.63,
        "free_cash_flow": -51888000.0,
        "net_income": -71109000.0,
        "operating_cash_flow": -51522000.0,
        "operating_income": -78194000.0,
        "stockholders_equity": 323127000.0,
        "total_assets": 358234000.0,
        "total_liabilities": 35107000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.10864768341859393,
        "roa_avg2y": -0.37020705022412653,
        "roa_period_end": -0.19849874662929817,
        "roe_avg2y": -0.9498233498741075,
        "roe_period_end": -0.22006517561206584
      }
    },
    {
      "accn": "0001193125-26-120873",
      "filed": "2026-03-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 166000.0,
        "cash": 21644000.0,
        "eps_diluted": -38.17,
        "free_cash_flow": -37528000.0,
        "net_income": -63854000.0,
        "operating_cash_flow": -37362000.0,
        "operating_income": -48400000.0,
        "stockholders_equity": -173396000.0,
        "total_assets": 25924000.0,
        "total_liabilities": 66598000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.4466017380357049
      }
    },
    {
      "accn": "0000950170-25-042759",
      "filed": "2025-03-20",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -112559000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-120873",
    "filed": "2026-03-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001709941.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001709941.json"
  },
  "ticker": "BIOA"
}